MIRA INFORM REPORT

 

 

Report Date :

22.01.2008

 

IDENTIFICATION DETAILS

 

Name :

ANTIBIOTIC SAZI IRAN COMPANY

 

 

Registered Office :

No.3, Bistoon St, Jahad (Fatemi) Sq Tehran 14316 63113

 

 

Country :

Iran

 

 

Date of Incorporation :

1995

 

 

Com. Reg. No.:

119201

 

 

Legal Form :

Privet Joint Stock Company 

 

 

Line of Business :

Manufacture of Raw Material Production, Mainly Oral Antibiotics from Penicillin

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

No Complaints

 

 

Litigation :

Clear

 

 


 

Company Details

 

Company Name:            Antibiotic Sazi Iran Company

 

Also Trade Name:           ASICO

 

Headquarter Address:  No.3, Bistoon St, Jahad (Fatemi) Sq

                                     Tehran 14316 63113

                                     Iran

 

 

Tel:                                 +98 21 88962978

                                    +98 21 88962979

                                          

Fax:                                 +98 21 88962478

                                            

Website:                          www.antibiotic-ir.com

 

E-mail:                              asico@antibiotic-ir.com

 

                   

Registration & Legal Details

 

Current Legal Form:              Privet Joint Stock Company 

 

Registration Address:            No.3, Bistoon St, Jahad (Fatemi) Sq

                                                  Tehran   

                                                            Iran

 

Registration Number:             119201

 

Registration Date:                   1995

 

Year Established:                   1995

 

Registration Town:                 Tehran

 

 

Capital

 

Currency:                                     Iranian Rials

Nominal capital:                          80,000,000,000

 

 

Number of Shares: 8,000,000

Type of Shares:  None Selected

Issued Shares: -

Value per share: IRI 10,000.00

                      

 

Shareholders

 

Shareholder Names/ Address

 

% of Voting/Non-Voting Capital

 

Farabi Pharmaceutical Co

Tehran

Iran

 

%38

Social Security Organization

Tehran

Iran

%32

Taamin Investment Company

Tehran

Iran

%10

Others

Iran

%20

 

 

Principals

 

Name:                                            Mr. Seyed Mehdi Mousavi

Position within the company:      Chairman

Country of Birth:                           Iran

Nationality:                                    Iranian

Can fluently speak:                       Farsi- English

 

 

Name:                                            Mr. Ali Aminlou

Position within the company:      Vice Chairman

Country of Birth:                           Iran

Nationality:                                    Iranian

Can fluently speak:                       Farsi, English

 

 

Name:                                          Mr. Kourosh Soleymani Meygouni

Position within the company:   Managing Director

Country of Birth:                         Iran

Nationality:                                  Iranian

Can fluently speak:                      Farsi

 

 

Name:                                          Mr. Mohamad Tahsiri

Position within the company:   Member

Country of Birth:                        Iran

Nationality:                                 Iranian

Can fluently speak:                     Farsi

 

 

Company Activities

 

Manufacture of Raw material production, mainly oral antibiotics from penicillin

 

Local Reporters consider the investigated company to be Medium their  field  of concern.

 

Operations

 

 

Employees

                                      

Company Employs:                  250

 

 

HQ Premises

 

Operates from:     Owned Offices, Warehouses, Factory

Location:              Central Business Area, Main Road

 

 Branch:

Antibiotic Sazi Iran Factory

5th Km, Khazar Abad Road

Sari

Iran

Branch is owned

 

 

Imports

 

Imports:                            

Import%:                      20% Raw Material, 15% Finished Good

Import from:              Germany, Swiss, Japan, India

Import terms:             letters of credit

Additional:                 alance of 65% purchased via local market

 

 

Export

    

Exports:                       Finished Goods

Export%:                      20%

Export from:              Persian Gulf Countries, CIS

Export terms:             letters of credit

 

 

Trading & Selling

 

Territory:                            80% Nationality, 20 % Internationally

Type of Customer:            General Public, Local Authorities

Terms of sales:                 Cash, letters of credit

Vehicles:                           Total number of vehicles: 40

 

 

 

Related Companies

 

Subject Dose not have related company

 

 

Banks

 

Bank Melli

Tehran

Iran

 

Bank Tejarat

Tehran

Iran

 

 

Financial Information

 

Source:       Mr. Ahmad Mohamadi (Secretary)  

Currency:   Iranian Rials - 000,000

 

 

 

Months

 

 

Date

 

Sales

 

12

 

29/03/2007

 

91000

 

12

 

29/03/2006

74000

 

12

29/03/2005

62000


 

Payments

 

Subject's payments reported to be: NO COMPLAINTS

 

 

interview & reporter comments

 

Name/Title:               Mr. Ahmad Mohamadi (Secretary)

 

In the interview conducted with Mr. Ahmad Mohamadi (Secretary), he Declined full financial information and bank account numbers citing the grounds of Company confidentiality.

 

 

 

Conclusion

 

Local Reputation: The company being investigated is considered by local reporters to be a 

Medium Trade Risk.

 

General Conclusion:

Local informants consider granting of credit to be a fair trade risk.

 

 Owner/Shareholders Comments:

Some of owners involved in the running of the business

 

Age of Business: Old Business

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions